Results for the company's Cepheus phase 3 trial showed a 60.9% improvement in eliminating cancer cells and a 43% reduction in the cancer progressing or causing death when its treatmentis used in ...

In this opinion piece, Richard Owen of the American Peanut Council argues for negotiating new trade deals and ...

In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...

Even after a hurricane’s immediate flooding threat goes away, residents could face a host of potential health problems from the water — and what it leaves behind.

Cobenfy targets cholinergic receptors instead of the dopamine receptors long addressed in current schizophrenia drugs — a new treatment approach to the disease.

As the rate of myopia in children grows, research is keeping a finger pointed at the fact much of our lives is spent indoors.

An examination of the cardiovascular risks, side effects associated with use of lecanemab therapy in patients with cardiovascular disease.

Regeneron and Sanofi on Friday said the green light covers Dupixent as an add-on maintenance treatment in certain adults with uncontrolled chronic obstructive pulmonary disease, or COPD, and makes ...

People in the United States can order more free Covid-19 tests from the federal government this fall as the country heads ...

Lawmakers passed a law designed to limit reproductive rights in Louisiana. But it may also limit patients’ chances of ...

AbbVie on Friday said the application covers telisotuzumab vedotin, or teliso-V, in adults with previously treated, locally advanced or metastatic epidermal growth factor receptor wild type, ...

Babies conceived through assisted reproductive technology are more likely to be born with a major heart defect, new research ...